Swiss medtech company at the forefront of eHealth and smart medical implants with initial focus on urology and digestive surgery. Management with a very successful track record in the implant business - Developed the gastric band business to 28% non-US market share CE marked implant RefluxStop™ - potential for a paradigm shift in anti-reflux surgery - CE Mark obtained in Q3 2018 after clinical trial with excellent and remarkable results Wireless disruptive Energizing Platform and eHealth platform technology, e-InVivo™. Remote-controlled implants powered wirelessly through intact skin and eHealth applications niche with focus on actions inside the body Huge IP portfolio with >1,000 patents and an impressive R&D pipeline >300 individual inventions - covering multiple aspects of the product, its application and method of use - 40 pipeline implants selected